Notification That Annual Report Will Be Submitted Late (nt 10-k)
| SEC FILE NUMBER | |||
| 001-35141 | |||
| CUSIP NUMBER | |||
| 759757 867 |
UNITEDSTATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM12b-25
NOTIFICATIONOF LATE FILING
(Checkone): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐Form 10-D ☐FormN-CEN☐FormN-CSR
| For Period Ended: December 31, 2022 | ||||
| ☐ Transition Report on Form10-K | ||||
| ☐ Transition Report on Form20-F | ||||
| ☐ Transition Report on Form11-K | ||||
| ☐ Transition Report on Form10-Q | ||||
| For the Transition Period Ended: | ||||
ReadInstruction (on back page) Before Preparing Form. Please Print or Type.
Nothingin this form shall be construed to imply that the Commission has verified any information contained herein.
Ifthe notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PARTI — REGISTRANT INFORMATION
RennovaHealth, Inc.
FullName of Registrant
FormerName if Applicable
400 South Australian Avenue, Suite 800
Addressof Principal Executive Office (Street and Number)
WestPalm Beach, FL 33401
City,State and Zip Code
PARTII — RULES 12b-25(b) AND (c)
Ifthe subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule12b-25(b),the following should be completed. (Check box if appropriate)
| (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; | ||||
| ☒ | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and | |||
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PARTIII — NARRATIVE
Statebelow in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof,could not be filed within the prescribed time period.
Rennova Health, Inc. (the “Company”)is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2022 withinthe prescribed time period because the Company is still compiling information for the Form 10-K and its auditors have not completed theiraudit of the financial statements for the year then ended. The Company expects to file its Form 10-K on or prior to the fifteenth calendarday following the prescribed due date.
Personswho are to respond to the collection of information contained in this form are not required to respond unless the form displaysa currently valid OMB control number.
(Attachextra Sheets if Needed)
PARTIV — OTHER INFORMATION
| (1) | Name and telephone number of person to contact in regard to this notification |
| Seamus Lagan | 561 | 855-1626 | ||||
| (Name) | (Area Code) | (Telephone Number) | ||||
| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section30 of the Investment Company Act of 1940 during the preceding 12months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). | |
| Yes☒No☐ | ||
| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? | |
| Yes☐No☒ |
| If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. | ||
2
RennovaHealth, Inc.
(Nameof Registrant as Specified in Charter)
hascaused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
| Date | March 31, 2023 | By | /s/ Seamus Lagan | |
| Seamus Lagan | ||||
| Chief Executive Officer |
3
Rennova Health (CE) (USOTC:RNVA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rennova Health (CE) (USOTC:RNVA)
Historical Stock Chart
From Jul 2023 to Jul 2024
 | {{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}} |
Loading Messages....
Rennova Health, Inc. News
Loading Messages....
`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `
`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `
FEATURED
•{{ article.source }} • {{ article.date}} {{article.time}}
`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/94054214\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1718628362,"date":"Mon Jun 17, 2024 ","time":"8:46 AM (1 month ago)","full_date":"June 17, 2024 8:46 AM","post_time":"June 17 2024","article_id":94054214,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/93872515\/form-nt-10-q-notification-of-inability-to-timely","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715890533,"date":"Thu May 16, 2024 ","time":"4:15 PM (2 months ago)","full_date":"May 16, 2024 4:15 PM","post_time":"May 16 2024","article_id":93872515,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone","short_text":"Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDroneThe U.S. Navy is looking to use the ZenaDrone 1000 for a variety of missions, including surveillance, search and...","one_line_short_text":"Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDroneThe U.S. Navy is looking to use the ZenaDrone 1000 for a variety of...","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/92581268\/epazz-inc-otc-pink-epaz-us-navy-collaboration-w","source":"InvestorsHub NewsWire","source_logo":"\/common\/images\/news-sources\/ihnw.png","tags":[],"timestamp":1700137927,"date":"Thu Nov 16, 2023 ","time":"7:32 AM (8 months ago)","full_date":"November 16, 2023 7:32 AM","post_time":"November 16 2023","article_id":92581268,"source_id":"ihnw","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/92417887\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1698784835,"date":"Tue Oct 31, 2023 ","time":"4:40 PM (9 months ago)","full_date":"October 31, 2023 4:40 PM","post_time":"October 31 2023","article_id":92417887,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/91865502\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1692649832,"date":"Mon Aug 21, 2023 ","time":"4:30 PM (11 months ago)","full_date":"August 21, 2023 4:30 PM","post_time":"August 21 2023","article_id":91865502,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/91820750\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1692103957,"date":"Tue Aug 15, 2023 ","time":"8:52 AM (11 months ago)","full_date":"August 15, 2023 8:52 AM","post_time":"August 15 2023","article_id":91820750,"source_id":"edgar2","media_url":null,"press_release":true}],"All News": [{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/94054214\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1718628362,"date":"Mon Jun 17, 2024 ","time":"8:46 AM (1 month ago)","full_date":"June 17, 2024 8:46 AM","post_time":"June 17 2024","article_id":94054214,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/93872515\/form-nt-10-q-notification-of-inability-to-timely","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715890533,"date":"Thu May 16, 2024 ","time":"4:15 PM (2 months ago)","full_date":"May 16, 2024 4:15 PM","post_time":"May 16 2024","article_id":93872515,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone","short_text":"Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDroneThe U.S. Navy is looking to use the ZenaDrone 1000 for a variety of missions, including surveillance, search and...","one_line_short_text":"Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDroneThe U.S. Navy is looking to use the ZenaDrone 1000 for a variety of...","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/92581268\/epazz-inc-otc-pink-epaz-us-navy-collaboration-w","source":"InvestorsHub NewsWire","source_logo":"\/common\/images\/news-sources\/ihnw.png","tags":[],"timestamp":1700137927,"date":"Thu Nov 16, 2023 ","time":"7:32 AM (8 months ago)","full_date":"November 16, 2023 7:32 AM","post_time":"November 16 2023","article_id":92581268,"source_id":"ihnw","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/92417887\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1698784835,"date":"Tue Oct 31, 2023 ","time":"4:40 PM (9 months ago)","full_date":"October 31, 2023 4:40 PM","post_time":"October 31 2023","article_id":92417887,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/91865502\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1692649832,"date":"Mon Aug 21, 2023 ","time":"4:30 PM (11 months ago)","full_date":"August 21, 2023 4:30 PM","post_time":"August 21 2023","article_id":91865502,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/rennova-health-ce-RNVA\/stock-news\/91820750\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1692103957,"date":"Tue Aug 15, 2023 ","time":"8:52 AM (11 months ago)","full_date":"August 15, 2023 8:52 AM","post_time":"August 15 2023","article_id":91820750,"source_id":"edgar2","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});
More Rennova Health, Inc. News Articles
